23 – 24 April 2025

Join Avance Clinical at the World Orphan Drug Congress USA in Boston, 23-24 April 2025

Join Avance Clinical at the World Orphan Drug Congress USA in Boston, 23-24 April 2025

Boston, USA
23-24 April 2025

Avance Clinical is pleased to announce its participation in the World Orphan Drug Congress USA, taking place in Boston on April 23-24, 2025. With the successful completion of over 60 clinical trials for rare diseases in the last five years, Avance Clinical continues to lead the way in supporting biotech companies navigating the complexities of orphan drug development.

As a full-service CRO specializing in early-phase trials, Avance Clinical provides tailored solutions for international biotech companies, leveraging its expertise in North America and beyond. Our deep understanding of Rare Disease clinical trials, regulatory landscapes, and patient-centric approaches ensures streamlined study execution and high-quality data to accelerate drug development.

 

Why Partner with
Avance Clinical for Your
Rare Disease Trial?

Proven Rare Disease Expertise

With over 50 rare and orphan disease trials completed globally in the last five years, Avance Clinical understands the unique challenges of managing small patient populations. Our team’s expertise ensures scientifically sound trial designs that maximize patient recruitment and data integrity.

Patient-Centric Approach

Avance Clinical prioritizes patient engagement and retention, working closely with experienced sites and advocacy groups. Our tailored recruitment strategies improve access and trial participation, ensuring that therapies reach those who need them most.

Regulatory & Study Design Excellence

Backed by 30 years of experience delivering FDA and EMA-quality data, Avance Clinical designs adaptive, patient-focused trials that align with regulatory requirements. Our strategic approach reduces time-to-market and enhances the likelihood of trial success.

Data Quality & Real-Time Oversight

We uphold data integrity and quality at every stage, leveraging advanced technologies and real-time endpoint monitoring to ensure insightful, reliable results—critical in rare disease trials with limited patient numbers.

Global Reach, Local Expertise

With operations spanning North America, Australia, and Asia, Avance Clinical provides seamless coordination across international sites while maintaining a deep understanding of regional regulatory nuances.

Meet Avance Clinical at the
World Orphan Drug Congress USA

John Mann

John Mann

Executive Vice President, North American Operations

John Mann's LinkedIn Profile

Read more

Kevin Leach

Kevin Leach

Senior Vice President, Scientific and Regulatory Affairs

Kevin Leach's LinkedIn Profile

Read more

Clint Henry

Clint Henry

Director of Business Development

Clint Henry's LinkedIn Profile

Read more

Kelly Brown

Kelly Brown

Project Director I

Kelly Brown's LinkedIn Profile

Book a meeting

Book a meeting - Generic
Terms and conditions

Related Events